电针治疗早期绝经潮热的随机假针对照试验
两组潮热评分均显著下降,但组间无差异;电针在更年期评定量表、绝经特异性生活质量量表(血管舒缩、心理社会、躯体维度)、匹兹堡睡眠质量指数及中医证候评分方面优于假针,且不良事件发生率相似。
要点
- 电针未显著改善早期绝经潮热评分,组间差异无统计学意义。
- 电针可改善睡眠质量及血管舒缩、心理社会、躯体等更年期症状。
- 电针对雌二醇、黄体生成素、卵泡刺激素水平无显著影响。
核心结论
- 电针不能显著改善早期绝经患者的潮热,但可提升睡眠质量并改善血管舒缩、心理社会及躯体维度的更年期症状。
主要发现
- 两组治疗后及随访期潮热评分均较基线显著下降(P < 0.001),但治疗结束及干预后12周两组潮热评分相似。
- 治疗第6周,电针组在更年期评定量表、绝经特异性生活质量量表(血管舒缩、心理社会、躯体维度)、匹兹堡睡眠质量指数及中医证候评分方面改善显著优于假针组(P < 0.05)。
- 绝经特异性生活质量量表(血管舒缩、心理社会维度)及匹兹堡睡眠质量指数总分的改善持续至随访期(P < 0.05)。
- 绝经特异性生活质量量表性功能维度评分组间及组内均无显著差异(P > 0.05)。
- 电针未较安慰剂显著降低雌二醇、黄体生成素或卵泡刺激素水平,两组不良事件发生率相似。
临床怎么用
- 对于早期绝经女性,电针可作为改善睡眠及血管舒缩、心理社会、躯体症状的辅助选项,但不应期望其显著减少潮热。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Electroacupuncture (EA) may affect the severity of hot flashes (HFs) associated with natural menopause and provide additional benefits for postmenopausal women. However, the evidence for its effectiveness in the management of early postmenopausal HFs remains inadequately understood. OBJECTIVE: We designed this trial to assess the efficacy and safety of EA for relieving early postmenopausal HFs. DESIGN, SETTING, PARTICIPANTS AND INTERVENTIONS: This randomized sham-controlled trial involved 72 women with HFs. The participants were divided equally into the intervention and control groups. The intervention group was treated with EA, while the control group was treated with sham acupuncture. The main acupoints used were Hegu (LI4), Guanyuan (RN4), Sanyinjiao (SP6), Taixi (KI3), Fuliu (KI7) and Shenshu (BL23). All participants received 18 treatment sessions, distributed across a 6-week period. The treatment was administered on three occasions per week, adhering to a fixed weekday schedule (Monday, Wednesday, Friday or Tuesday, Thursday, Saturday) with a minimum interval of one day between sessions. Each patient received a 12-week follow-up. MAIN OUTCOME MEASURES: The HF score was the primary outcome. Participants documented the frequency and severity of HFs in a 7-day symptom diary, which provided data for calculating the HF score. Secondary outcomes were the Menopause Rating Scale (MRS), Menopause-Specific Quality of Life Questionnaire (MENQOL), Pittsburgh Sleep Quality Index (PSQI) and Traditional Chinese Medicine Syndrome Score Scale (TCMSSS), as well as estradiol (E2), luteinizing hormone (LH) and follicle-stimulating hormone (FSH) levels. RESULTS: Both groups demonstrated significant reductions in HF scores after the treatment and during the follow-up (P < 0.001). Immediately after completion of the 6-week treatment cycle and at 12 weeks post-intervention, the HF scores were similar in both groups. At week 6, the intervention group showed significantly greater improvements in MRS, MENQOL (vasomotor, psychosocial, and physical), PSQI and TCMSSS scores (P < 0.05). The improvements in the MENQOL (vasomotor, and psychosocial) and PSQI total scores persisted through the follow-up (P < 0.05). However, the results showed no significant inter- or intragroup differences in sexual scores on the MENQOL (P > 0.05). EA did not significantly decrease E2, LH or FSH levels compared to placebo. The incidence of adverse events was similar in both groups. CONCLUSION: EA does not significantly improve HFs in early postmenopausal patients. However, it enhances the quality of sleep and decreases menopausal symptoms across vasomotor, psychosocial and physical domains. TRIAL REGISTRATION: Chinese Clinical Trial Registry (http://www.chictr.org.cn); Trial ID: ChiCTR2300072002. Please cite this article as: Wang HX, Yu XT, Hu J, Chen JJ, Mei YT, Chen YF. Electroacupuncture for hot flashes in early menopause: A randomized sham-controlled trial. J Integr Med. 2025; 23(5):519-527.
引用
- Wang HX, Yu XT, Hu J, et al. Electroacupuncture for hot flashes in early menopause: A randomized sham-controlled trial. J Integr Med. 2025. PMID: 40846522. doi:10.1016/j.joim.2025.07.008
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。